News
Nurses enhance chronic kidney disease (CKD) care by implementing a palliative CKD care framework, addressing barriers, and ...
AbbVie has finally claimed FDA approval for its advanced Parkinson's disease therapy Vyalev, 18 months after the US regulator turned it down with a request for more data. Now, Vyalev (foscarbidopa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback